AU2003261067A8 - Modified release ketoprofen dosage form - Google Patents

Modified release ketoprofen dosage form

Info

Publication number
AU2003261067A8
AU2003261067A8 AU2003261067A AU2003261067A AU2003261067A8 AU 2003261067 A8 AU2003261067 A8 AU 2003261067A8 AU 2003261067 A AU2003261067 A AU 2003261067A AU 2003261067 A AU2003261067 A AU 2003261067A AU 2003261067 A8 AU2003261067 A8 AU 2003261067A8
Authority
AU
Australia
Prior art keywords
dosage form
modified release
release ketoprofen
ketoprofen dosage
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003261067A
Other versions
AU2003261067A1 (en
Inventor
Judita Sirca
Milojka Mohar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Publication of AU2003261067A8 publication Critical patent/AU2003261067A8/en
Publication of AU2003261067A1 publication Critical patent/AU2003261067A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU2003261067A 2002-09-11 2003-09-10 Modified release ketoprofen dosage form Abandoned AU2003261067A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200200220A SI21301A (en) 2002-09-11 2002-09-11 Pharmaceutical form with controlled release
SIP-200200220 2002-09-11
PCT/SI2003/000033 WO2004024128A2 (en) 2002-09-11 2003-09-10 Modified release ketoprofen dosage form

Publications (2)

Publication Number Publication Date
AU2003261067A8 true AU2003261067A8 (en) 2004-04-30
AU2003261067A1 AU2003261067A1 (en) 2004-04-30

Family

ID=31989658

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261067A Abandoned AU2003261067A1 (en) 2002-09-11 2003-09-10 Modified release ketoprofen dosage form

Country Status (4)

Country Link
EP (1) EP1539113A2 (en)
AU (1) AU2003261067A1 (en)
SI (1) SI21301A (en)
WO (1) WO2004024128A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
PT1897558E (en) * 2005-06-09 2013-11-06 Norgine Bv Solid preparation of 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-one
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
KR100762847B1 (en) * 2006-01-27 2007-10-04 씨제이 주식회사 Multiple unit type sustained release oral formulation and process for the preparation thereof
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi Drug delivery composition
CN104825397A (en) 2006-04-03 2015-08-12 伊萨·奥迪迪 Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
JP5865904B2 (en) 2010-06-16 2016-02-17 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Novel controlled release dosage forms of xanthine oxidoreductase inhibitors or xanthine oxidase inhibitors
ES2394888B1 (en) * 2011-06-15 2013-09-23 Farmalider, S.A. PHARMACEUTICAL FORM OF MODIFIED RELEASE OF DEXKETOPROPHENE AND INHIBITOR OF THE PUMP OF PROTONS AND USE OF THE SAME.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6144811A (en) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd Sustained release diclofenac sodium pharmaceutical
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
EP1017370B1 (en) * 1997-09-11 2003-10-29 Nycomed Danmark ApS MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
FR2792527B1 (en) * 1999-04-22 2004-08-13 Ethypharm Lab Prod Ethiques KETOPROFENE MICROGRANULES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
WO2004024128A2 (en) 2004-03-25
AU2003261067A1 (en) 2004-04-30
SI21301A (en) 2004-04-30
EP1539113A2 (en) 2005-06-15
WO2004024128A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
EP1553925A4 (en) Modified release oral dosage form
HK1107002A1 (en) Modified release ibuprofen dosage form
PL373914A1 (en) Immediate release dosage forms containing solid drug dispersions
IL174343A0 (en) Delayed released dosage forms
GB0217225D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
TWI319318B (en) Modified release pharmaceutical formulation
AU2003260803A8 (en) Sustained release pharmaceutical composition
PL376840A1 (en) Prolonged release pharmaceutical composition
IL165069A0 (en) Immediate release pharmaceutical formulation
HK1072194A1 (en) Oral dosage form for controlled drug release
IL163887A0 (en) Controlled release dosage forms
AU2003261067A8 (en) Modified release ketoprofen dosage form
EP1478353A4 (en) Sustained release pharmaceutical composition
AU2003255890A8 (en) Nitrofurantoin controlled release dosage form
HUP0401599A3 (en) Extended release oral dosage form
GB0322848D0 (en) Tetracycline controlled release pharmaceutical dosage form
EP1652522A4 (en) Sustained release tablet for oral use
ZA200702694B (en) Modified release ibuprofen dosage form
AU2003220479A1 (en) Modified release dosage forms
GB0224498D0 (en) Medicinal compounds
GB0224494D0 (en) Medicinal compounds
GB0224502D0 (en) Medicinal compounds
GB0224508D0 (en) Medicinal compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase